Core Laboratories N.V.CLBNYSE

Revenue (LTM)

$527M

+0.5% YoY

Net Income (LTM)

$32M

+1.3% YoY

Free Cash Flow

$23M

Revenue CAGR (5Y)

+1.6%

—Marginsstable

FCF$0.0B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	470	490↑4.1%	510↑4.1%	524↑2.8%	527↑0.5%
Gross Profit	84	79↓5.9%	94↑19.2%	88↓6.0%	94↑6.7%
Operating Income	45	42↓8.3%	55↑31.6%	59↑7.2%	49↓16.6%
Net Income	20	19↓1.4%	37↑88.5%	31↓14.4%	32↑1.3%
EBITDA	64	59↓8.0%	70↑20.0%	73↑4.0%	64↓13.3%
EPS Diluted	0.42	0.42↓0.0%	0.77↑83.3%	0.66↓14.3%	0.68↑3.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	18	15↓12.9%	15↓2.0%	19↑26.7%	23↑19.3%
Total Current Assets	189	212↑12.0%	223↑5.4%	227↑1.6%	222↓1.9%
Total Assets	581	578↓0.4%	586↑1.4%	590↑0.7%	597↑1.1%
Total Current Liabilities	91	103↑13.6%	88↓14.6%	98↑10.8%	107↑9.8%
Total Liabilities	420	389↓7.3%	357↓8.4%	333↓6.7%	317↓4.7%
Total Equity	156	184↑17.8%	225↑22.0%	252↑12.1%	280↑11.0%
Total Debt	250	222↓11.1%	215↓3.1%	180↓16.4%	206↑14.5%
Net Debt	233	207↓11.0%	200↓3.2%	161↓19.6%	183↑14.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	37	25↓31.8%	25↓0.7%	56↑127.5%	37↓34.1%
Capital Expenditure	-14	-10↑24.5%	-11↓3.6%	-13↓23.1%	-15↓12.0%
Free Cash Flow	23	15↓36.0%	14↓3.6%	43↑205.1%	23↓47.9%
Stock-Based Comp	19	8↓59.4%	14↑80.1%	4↓73.1%	7↑90.1%
Net Change in Cash	4	-2↓158.4%	-0↑86.5%	4↑1410.7%	4↓8.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance